Author:
DeAtley Teresa,Denlinger-Apte Rachel L.,Cioe Patricia A.,Colby Suzanne M.,Cassidy Rachel N.,Clark Melissa A.,Donny Eric C.,Tidey Jennifer W.
Funder
National Institute on Drug Abuse
Food and Drug Administration
Center for Tobacco Products
National Institutes of Health
Subject
Public Health, Environmental and Occupational Health,Epidemiology
Reference46 articles.
1. Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls;AhnAllen;Nicotine Tob. Res.,2015
2. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial;Anthenelli;Lancet,2016
3. Biochemical verification of tobacco use and abstinence: 2019 update;Benowitz;Nicotine & Tobacco Research,2019
4. Reliability and validity of a smoking timeline follow-back interview;Brown;Psychol. Addict. Behav.,1998
5. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression;Callaghan;J. Psychiatr. Res.,2014
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献